Ilaria G. Marcon
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Correction: Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy.
Journal: Clinical and experimental medicine
Published: December 17, 2025
Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy.
Journal: Clinical and experimental medicine
Published: May 28, 2025
Retrospective-Prospective Observational Study of Italian Patients Treated in Melanoma Adjuvant Cohort MAP-MADAM (Maximing ADjuvAnt MAP): Interim Analysis.
Journal: Cancers
Published: October 09, 2024
Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program.
Journal: Cancer management and research
Published: July 12, 2023
Real-World Evaluation of the Management, Treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy.
Journal: Advances in therapy
Published: April 26, 2023
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).
Journal: Targeted oncology
Published: October 11, 2021
When primary hyperparathyroidism comes as good news.
Journal: Endocrinology, diabetes & metabolism case reports
Published: April 28, 2020
Primary melanoma of the stomach treated by BRAF inhibitor and immunotherapy.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: March 23, 2016
Last Updated: 09/26/2026